New Hepatitis-C drug raises hope at a hefty price

New Hepatitis-C drug raises hope at a hefty price More

A new drug has a 90 to 100 percent chance of curing the Hepatitis C virus, but costs tens of thousands of dollars for a course of treatment. The announcement by the manufacturer that it earned more than $2 billion in the year’s first quarter raises the question, who should pay when drugs are highly effective, but extremely expensive? Hari Sreenivasan reports on the profits, coverage and costs.

AIR DATE 4/23/14